Precision Medicine Market Size By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics), By Application (Oncology, Immunology, CNS, Respiratory), By End-use (Pharmaceutical Companies, Diagnostic Companies, Healthcare IT Companies); By Region (North America, Europe, Asia Pacific, Middle East and Africa and Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
Global precision medicine market was valued at US$ 1221.93 million in 2018 and is anticipated to reach US$ 6643.36 million by 2027, growing at an estimated CAGR of 20.9% over the forecast period. Precision medicine is grounded on a unique perception that two people with the similar disease is not essential to respond similarly to that specific disease. However, it depends on the environment surrounding the patient's genes and symptoms and their influence. It also depends on the ability of patients to adapt to that particular disease, which helps the doctors and researchers to coordinate the care they need. Precision medicine usually involves the use of system biology to determine the cause for molecular-level disease in an individual patient followed by the use of standardized drugs to cope with the condition of individual patients. Precision medicine provides other advantages, such as effective diagnosis personalized to patient needs and disease type. In fact, precision medicine can minimize treatment costs and help in lowering the routine drug administration. All these factors are expected to drive growth of the global precision medicine market. Precision medicine is a developing approach for treatment of diseases and prevention that takes into consideration individual differences in genes and lifestyle. “This approach will help doctors and researchers to forecast more accurately regarding which treatment and prevention approaches to be taken for a particular disease and different classes of people. It is intact with static approach, in which disease diagnosis and tactics are taken for person, with less contemplation for the alterations arises amongst people.
The precision medicine market has witnessed huge outbreak in the digital precision medicine domain. As electronic biomarkers are gaining status as an approach in defining more precise outcome measures and clinical end points. These majorly includes cognitive tests in the form of games on devices, mood assessments, by voice recording and actigraphy which is the major criteria for the patient movement in real-time using mobile sensors. Moreover, advent of novel technology stages enables to reinvent the whole research and development approach. Precision medicine satisfies this potential through the introduction of cutting-edge technologies to understand the biological accent of the disease, and facilitates in developing innovative therapies which are custom-made for patients. Boosting data generation, advancements in developing insights, personalization of healthcare sector, have added sufficient market space for precision medicines in the market. One of the major factors that is driving the market is the rising investments by the companies who are engaged in precision medicines and technologies. Financial investors have predicted wide opportunities in the market. Michael Allen, CFO at OSF HealthCare has stated that current investors focusing in the precision medicine and technology are not expecting millions of dollars initially. But after years go by, advancements in the genetic space will occasionally help companies automatically generate huge profits. Companies like OSF, has been providing venture capital funds for long-term financial planning to invest in the healthcare disruption wave.
During the forecast period, the demand for precision medicine market is expected to grow at a productive rate. The rise in global cancer incidence and an increase in the ageing population vulnerable to disease are expected to increase demand for precision medicine. It is anticipated that government initiative & grants and private companies investing in precision medicine’s research and development would fuel market growth. Precision medicine, a synthesis of molecular biology and machine biology techniques, is a new method for treating and preventing disease.
End User Insights
Healthcare IT companies held the largest share in the Precision Medicine Market owing to the rising emphasis on providing personalized medicine in hospitals. The healthcare sector has been very much focused on providing different treatment for the same disease type due to the different gene reactions on people. As hospitals and health systems trying to make their presence through technological break-through, exploiting the new revolution of genomics and precision medicine, there's no deficiency of technology providers, some of them newly-introduced start-ups, helps healthcare providers in gathering the essential data and implementing the process through delivering it to targeted patient care. Precision medicine software is a vital technology cast-off by healthcare providers for analysing rare disorders, spotting infectious diseases, and identifying therapeutic targets in neoplasms (abnormal growth of tissue in certain part of the body)
Application Insights
The global precision medicine market segmented on the basis of application is expected to be dominated by the oncology segment. Practices for precision medicine are majorly intended to improve treatment for oncological disorders, with a major market dominance over other categories. According to the data reported in clinicaltrials.gov, the United States and some European countries are the major hubs for oncology, internationally, to perform and attract patient pool for precision medicine applications. The government's high support through funding and rapid growth of genomic analysis is expected over the forecast period to increase the growth of the precision medicine market at a rapid rate. Precision medicine is an approach adopted for patient care that permits doctors to select treatments that are to be provided to help patients based on a genetic change of their disease. This is also known as personalized medicine. Recent advancement in biotechnology have accelerated the pace of this area of study. A major example of precision medicine is when a person is diagnosed with cancer, they are entitled same treatment as received by others who was then suffering from the same type of cancer. But different people respond differently. After long research studies conducted by scientists, they came to a conclusion that the patients’ tumors have genetic dynamics that boosts cancer to grow and spread. The major assumption of precision medicines is that treatments will be tailored to the genetic changes in accordance to individual needs.
Regional Insights
Led by the U.S., in 2018 North America was the leading Precision Medicine Market. The market is driven by rising acceptance of NGS strategies and healthcare IT systems in clinical workflow along with supportive government policies and funding. However, due to the low cost of clinical trials of newly developed precision medicines and diagnostic products, Asia Pacific is projected to witness the highest CAGR over the forecast period. In addition, rising levels of disposable income and emerging-country growth will further boost the market. For example, In September 2018, the All of Us Research initiative taken by the National Institutes of Health (NIH) provided funds which amounted to US$ 28.6 million to three genome centers in North America. The funding initiative supported the generation of genomic data from biosamples by these centers is a critical constituent to precision medicine findings. The United States government has been continuously supporting the precision medicines. In 2015, President Obama announced that he's introducing the Precision Medicine Initiative which revolutionize the way of improving healthcare and treat disease in the most effective way. The future trend of precision medicine will permit health care providers to adapt with the existing treatment and prevention strategies to consumer’s unique attributes, which includes their genome sequence, past health, patients daily routine, and food habits. To get acquainted with the modifications, people need to integrate many vivid kinds of information’s regarding patients collected through health care providers and the patients themselves.
Precision Medicines Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of precision medicine market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The primary participants engaged in precision medicine market include Novartis, Qiagen, Biocrates Life Sciences, Pfizer, Eagle Genomics, Tepnel Pharma Services, Intomics, NanoString Technologies, Quest Diagnostics, Menarini Silicon Biosystems, Teva Pharmaceutical and Roche amongst others. The players follow strategic initiatives such as innovotaion, product development, expansion, and acquisition to strengthen their market position.
Precision Medicines Market:
- By Technology
- Big Data Analytics
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Companion Diagnostics
- By Application
- Oncology
- Immunology
- CNS
- Respiratory
- By End User
- Pharmaceutical Companies
- Diagnostic Companies
- Healthcare IT Companies
- By Region
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Precision Medicines Market
6. Market
Synopsis: Precision Medicines Market
7. Precision
Medicines Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Precision Medicines Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Precision Medicines Market
7.6. Porter’s
Five Force Analysis
8. Global
Precision Medicines Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Precision Medicines Market Revenue (US$ Mn)
8.2. Global
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
8.2.1. Big Data
Analytics
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. Bioinformatics
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2018
8.2.2.3. Market
Forecast, 2019 – 2027
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2018
8.2.2.5.1.2. Market
Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2018
8.2.2.5.2.2. Market
Forecast, 2019 – 2027
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2018
8.2.2.5.3.2. Market
Forecast, 2019 – 2027
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2018
8.2.2.5.4.2. Market
Forecast, 2019 – 2027
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2018
8.2.2.5.5.2. Market
Forecast, 2019 – 2027
8.2.3. Gene
Sequencing
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2018
8.2.3.3. Market
Forecast, 2019 – 2027
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2018
8.2.3.5.1.2. Market
Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2018
8.2.3.5.2.2. Market
Forecast, 2019 – 2027
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2018
8.2.3.5.3.2. Market
Forecast, 2019 – 2027
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2018
8.2.3.5.4.2. Market
Forecast, 2019 – 2027
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2018
8.2.3.5.5.2. Market
Forecast, 2019 – 2027
8.2.4. Drug
Discovery
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 – 2018
8.2.4.3. Market
Forecast, 2019 – 2027
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 – 2018
8.2.4.5.1.2. Market
Forecast, 2019 – 2027
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2018
8.2.4.5.2.2. Market
Forecast, 2019 – 2027
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2018
8.2.4.5.3.2. Market
Forecast, 2019 – 2027
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2018
8.2.4.5.4.2. Market
Forecast, 2019 – 2027
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 – 2018
8.2.4.5.5.2. Market
Forecast, 2019 – 2027
8.2.5. Companion
Diagnostics
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 – 2018
8.2.5.3. Market
Forecast, 2019 – 2027
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 – 2018
8.2.5.5.1.2. Market
Forecast, 2019 – 2027
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 – 2018
8.2.5.5.2.2. Market
Forecast, 2019 – 2027
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 – 2018
8.2.5.5.3.2. Market
Forecast, 2019 – 2027
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 – 2018
8.2.5.5.4.2. Market
Forecast, 2019 – 2027
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 – 2018
8.2.5.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Technology
9. Global
Precision Medicines Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Oncology
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Immunology
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.2.3. CNS
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 – 2018
9.2.3.3. Market
Forecast, 2019 – 2027
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 – 2018
9.2.3.5.1.2. Market
Forecast, 2019 – 2027
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2018
9.2.3.5.2.2. Market
Forecast, 2019 – 2027
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2018
9.2.3.5.3.2. Market
Forecast, 2019 – 2027
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2018
9.2.3.5.4.2. Market
Forecast, 2019 – 2027
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 – 2018
9.2.3.5.5.2. Market
Forecast, 2019 – 2027
9.2.4. Respiratory
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 – 2018
9.2.4.3. Market
Forecast, 2019 – 2027
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 – 2018
9.2.4.5.1.2. Market
Forecast, 2019 – 2027
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2018
9.2.4.5.2.2. Market
Forecast, 2019 – 2027
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2018
9.2.4.5.3.2. Market
Forecast, 2019 – 2027
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2018
9.2.4.5.4.2. Market
Forecast, 2019 – 2027
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 – 2018
9.2.4.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global
Precision Medicines Market Analysis and Forecasts, 2019 – 2027
10.1. Overview
10.2. Global
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
10.2.1. Pharmaceutical
Companies
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2018
10.2.1.3. Market
Forecast, 2019 – 2027
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2018
10.2.1.5.1.2. Market
Forecast, 2019 – 2027
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2018
10.2.1.5.2.2. Market
Forecast, 2019 – 2027
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2018
10.2.1.5.3.2. Market
Forecast, 2019 – 2027
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2018
10.2.1.5.4.2. Market
Forecast, 2019 – 2027
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2018
10.2.1.5.5.2. Market
Forecast, 2019 – 2027
10.2.2. Diagnostic
Companies
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2018
10.2.2.3. Market
Forecast, 2019 – 2027
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2018
10.2.2.5.1.2. Market
Forecast, 2019 – 2027
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2018
10.2.2.5.2.2. Market
Forecast, 2019 – 2027
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2018
10.2.2.5.3.2. Market
Forecast, 2019 – 2027
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2018
10.2.2.5.4.2. Market
Forecast, 2019 – 2027
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2018
10.2.2.5.5.2. Market
Forecast, 2019 – 2027
10.2.3. Healthcare
IT Companies
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2018
10.2.3.3. Market
Forecast, 2019 – 2027
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2018
10.2.3.5.1.2. Market
Forecast, 2019 – 2027
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2018
10.2.3.5.2.2. Market
Forecast, 2019 – 2027
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2018
10.2.3.5.3.2. Market
Forecast, 2019 – 2027
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2018
10.2.3.5.4.2. Market
Forecast, 2019 – 2027
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2018
10.2.3.5.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By End
User
11. North
America Precision Medicines Market Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1. North
America Precision Medicines Market Revenue (US$ Mn)
11.2. North
America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
11.2.1. Big
Data Analytics
11.2.2. Bioinformatics
11.2.3. Gene
Sequencing
11.2.4. Drug
Discovery
11.2.5. Companion
Diagnostics
11.3. North
America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1. Oncology
11.3.2. Immunology
11.3.3. CNS
11.3.4. Respiratory
11.4. North
America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
11.4.1. Pharmaceutical
Companies
11.4.2. Diagnostic
Companies
11.4.3. Healthcare
IT Companies
11.5. North
America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
11.5.1.1.1. Big
Data Analytics
11.5.1.1.2. Bioinformatics
11.5.1.1.3. Gene
Sequencing
11.5.1.1.4. Drug
Discovery
11.5.1.1.5. Companion
Diagnostics
11.5.1.2. U.S
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1. Oncology
11.5.1.2.2. Immunology
11.5.1.2.3. CNS
11.5.1.2.4. Respiratory
11.5.1.3. U.S
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
11.5.1.3.1. Pharmaceutical
Companies
11.5.1.3.2. Diagnostic
Companies
11.5.1.3.3. Healthcare
IT Companies
11.5.2. Canada
11.5.2.1. Canada
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
11.5.2.1.1. Big
Data Analytics
11.5.2.1.2. Bioinformatics
11.5.2.1.3. Gene
Sequencing
11.5.2.1.4. Drug
Discovery
11.5.2.1.5. Companion
Diagnostics
11.5.2.2. Canada
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1. Oncology
11.5.2.2.2. Immunology
11.5.2.2.3. CNS
11.5.2.2.4. Respiratory
11.5.2.3. Canada
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
11.5.2.3.1. Pharmaceutical
Companies
11.5.2.3.2. Diagnostic
Companies
11.5.2.3.3. Healthcare
IT Companies
11.5.3. Mexico
11.5.3.1. Mexico
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
11.5.3.1.1. Big
Data Analytics
11.5.3.1.2. Bioinformatics
11.5.3.1.3. Gene
Sequencing
11.5.3.1.4. Drug
Discovery
11.5.3.1.5. Companion
Diagnostics
11.5.3.2. Mexico
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1. Oncology
11.5.3.2.2. Immunology
11.5.3.2.3. CNS
11.5.3.2.4. Respiratory
11.5.3.3. Mexico
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
11.5.3.3.1. Pharmaceutical
Companies
11.5.3.3.2. Diagnostic
Companies
11.5.3.3.3. Healthcare
IT Companies
11.5.4. Rest of
North America
11.5.4.1. Rest
of North America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
11.5.4.1.1. Big
Data Analytics
11.5.4.1.2. Bioinformatics
11.5.4.1.3. Gene
Sequencing
11.5.4.1.4. Drug
Discovery
11.5.4.1.5. Companion
Diagnostics
11.5.4.2. Rest
of North America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.4.2.1. Oncology
11.5.4.2.2. Immunology
11.5.4.2.3. CNS
11.5.4.2.4. Respiratory
11.5.4.3. Rest
of North America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
End User
11.5.4.3.1. Pharmaceutical
Companies
11.5.4.3.2. Diagnostic
Companies
11.5.4.3.3. Healthcare
IT Companies
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Technology
11.6.3. By
Application
11.6.4. By End
User
12. Europe
Precision Medicines Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Europe
Precision Medicines Market Revenue (US$ Mn)
12.2. Europe
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
12.2.1. Big
Data Analytics
12.2.2. Bioinformatics
12.2.3. Gene
Sequencing
12.2.4. Drug
Discovery
12.2.5. Companion
Diagnostics
12.3. Europe
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1. Oncology
12.3.2. Immunology
12.3.3. CNS
12.3.4. Respiratory
12.4. Europe
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
12.4.1. Pharmaceutical
Companies
12.4.2. Diagnostic
Companies
12.4.3. Healthcare
IT Companies
12.5. Europe
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.1.1.1. Big
Data Analytics
12.5.1.1.2. Bioinformatics
12.5.1.1.3. Gene
Sequencing
12.5.1.1.4. Drug
Discovery
12.5.1.1.5. Companion
Diagnostics
12.5.1.2. France
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1. Oncology
12.5.1.2.2. Immunology
12.5.1.2.3. CNS
12.5.1.2.4. Respiratory
12.5.1.3. France
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
12.5.1.3.1. Pharmaceutical
Companies
12.5.1.3.2. Diagnostic
Companies
12.5.1.3.3. Healthcare
IT Companies
12.5.2. The UK
12.5.2.1. The
UK Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.2.1.1. Big
Data Analytics
12.5.2.1.2. Bioinformatics
12.5.2.1.3. Gene
Sequencing
12.5.2.1.4. Drug
Discovery
12.5.2.1.5. Companion
Diagnostics
12.5.2.2. The
UK Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1. Oncology
12.5.2.2.2. Immunology
12.5.2.2.3. CNS
12.5.2.2.4. Respiratory
12.5.2.3. The
UK Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
12.5.2.3.1. Pharmaceutical
Companies
12.5.2.3.2. Diagnostic
Companies
12.5.2.3.3. Healthcare
IT Companies
12.5.3. Spain
12.5.3.1. Spain
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.3.1.1. Big
Data Analytics
12.5.3.1.2. Bioinformatics
12.5.3.1.3. Gene
Sequencing
12.5.3.1.4. Drug
Discovery
12.5.3.1.5. Companion
Diagnostics
12.5.3.2. Spain
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1. Oncology
12.5.3.2.2. Immunology
12.5.3.2.3. CNS
12.5.3.2.4. Respiratory
12.5.3.3. Spain
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
12.5.3.3.1. Pharmaceutical
Companies
12.5.3.3.2. Diagnostic
Companies
12.5.3.3.3. Healthcare
IT Companies
12.5.4. Germany
12.5.4.1. Germany
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.4.1.1. Big
Data Analytics
12.5.4.1.2. Bioinformatics
12.5.4.1.3. Gene
Sequencing
12.5.4.1.4. Drug
Discovery
12.5.4.1.5. Companion
Diagnostics
12.5.4.2. Germany
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1. Oncology
12.5.4.2.2. Immunology
12.5.4.2.3. CNS
12.5.4.2.4. Respiratory
12.5.4.3. Germany
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
12.5.4.3.1. Pharmaceutical
Companies
12.5.4.3.2. Diagnostic
Companies
12.5.4.3.3. Healthcare
IT Companies
12.5.5. Italy
12.5.5.1. Italy
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.5.1.1. Big
Data Analytics
12.5.5.1.2. Bioinformatics
12.5.5.1.3. Gene
Sequencing
12.5.5.1.4. Drug
Discovery
12.5.5.1.5. Companion
Diagnostics
12.5.5.2. Italy
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1. Oncology
12.5.5.2.2. Immunology
12.5.5.2.3. CNS
12.5.5.2.4. Respiratory
12.5.5.3. Italy
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
12.5.5.3.1. Pharmaceutical
Companies
12.5.5.3.2. Diagnostic
Companies
12.5.5.3.3. Healthcare
IT Companies
12.5.6. Nordic
Countries
12.5.6.1. Nordic
Countries Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
12.5.6.1.1. Big
Data Analytics
12.5.6.1.2. Bioinformatics
12.5.6.1.3. Gene
Sequencing
12.5.6.1.4. Drug
Discovery
12.5.6.1.5. Companion
Diagnostics
12.5.6.2. Nordic
Countries Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
12.5.6.2.1. Oncology
12.5.6.2.2. Immunology
12.5.6.2.3. CNS
12.5.6.2.4. Respiratory
12.5.6.3. Nordic
Countries Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End
User
12.5.6.3.1. Pharmaceutical
Companies
12.5.6.3.2. Diagnostic
Companies
12.5.6.3.3. Healthcare
IT Companies
12.5.6.4. Nordic
Countries Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux
Union Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.7.1.1. Big
Data Analytics
12.5.7.1.2. Bioinformatics
12.5.7.1.3. Gene
Sequencing
12.5.7.1.4. Drug
Discovery
12.5.7.1.5. Companion
Diagnostics
12.5.7.2. Benelux
Union Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.2.1. Oncology
12.5.7.2.2. Immunology
12.5.7.2.3. CNS
12.5.7.2.4. Respiratory
12.5.7.3. Benelux
Union Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
12.5.7.3.1. Pharmaceutical
Companies
12.5.7.3.2. Diagnostic
Companies
12.5.7.3.3. Healthcare
IT Companies
12.5.7.4. Benelux
Union Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The
Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest
of Europe Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
12.5.8.1.1. Big
Data Analytics
12.5.8.1.2. Bioinformatics
12.5.8.1.3. Gene
Sequencing
12.5.8.1.4. Drug
Discovery
12.5.8.1.5. Companion
Diagnostics
12.5.8.2. Rest
of Europe Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.8.2.1. Oncology
12.5.8.2.2. Immunology
12.5.8.2.3. CNS
12.5.8.2.4. Respiratory
12.5.8.3. Rest
of Europe Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End
User
12.5.8.3.1. Pharmaceutical
Companies
12.5.8.3.2. Diagnostic
Companies
12.5.8.3.3. Healthcare
IT Companies
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Technology
12.6.3. By
Application
12.6.4. By End
User
13. Asia Pacific
Precision Medicines Market Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Asia
Pacific Precision Medicines Market Revenue (US$ Mn)
13.2. Asia
Pacific Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
13.2.1. Big
Data Analytics
13.2.2. Bioinformatics
13.2.3. Gene
Sequencing
13.2.4. Drug
Discovery
13.2.5. Companion
Diagnostics
13.3. Asia
Pacific Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
13.3.1. Oncology
13.3.2. Immunology
13.3.3. CNS
13.3.4. Respiratory
13.4. Asia
Pacific Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
13.4.1. Pharmaceutical
Companies
13.4.2. Diagnostic
Companies
13.4.3. Healthcare
IT Companies
13.5. Asia
Pacific Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.1.1.1. Big
Data Analytics
13.5.1.1.2. Bioinformatics
13.5.1.1.3. Gene
Sequencing
13.5.1.1.4. Drug
Discovery
13.5.1.1.5. Companion
Diagnostics
13.5.1.2. China
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1. Oncology
13.5.1.2.2. Immunology
13.5.1.2.3. CNS
13.5.1.2.4. Respiratory
13.5.1.3. China
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1.3.1. Pharmaceutical
Companies
13.5.1.3.2. Diagnostic
Companies
13.5.1.3.3. Healthcare
IT Companies
13.5.2. Japan
13.5.2.1. Japan
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.2.1.1. Big
Data Analytics
13.5.2.1.2. Bioinformatics
13.5.2.1.3. Gene
Sequencing
13.5.2.1.4. Drug
Discovery
13.5.2.1.5. Companion
Diagnostics
13.5.2.2. Japan
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1. Oncology
13.5.2.2.2. Immunology
13.5.2.2.3. CNS
13.5.2.2.4. Respiratory
13.5.2.3. Japan
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
13.5.2.3.1. Pharmaceutical
Companies
13.5.2.3.2. Diagnostic
Companies
13.5.2.3.3. Healthcare
IT Companies
13.5.3. India
13.5.3.1. India
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.3.1.1. Big
Data Analytics
13.5.3.1.2. Bioinformatics
13.5.3.1.3. Gene
Sequencing
13.5.3.1.4. Drug
Discovery
13.5.3.1.5. Companion
Diagnostics
13.5.3.2. India
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1. Oncology
13.5.3.2.2. Immunology
13.5.3.2.3. CNS
13.5.3.2.4. Respiratory
13.5.3.3. India
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
13.5.3.3.1. Pharmaceutical
Companies
13.5.3.3.2. Diagnostic
Companies
13.5.3.3.3. Healthcare
IT Companies
13.5.4. New
Zealand
13.5.4.1. New
Zealand Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
13.5.4.1.1. Big
Data Analytics
13.5.4.1.2. Bioinformatics
13.5.4.1.3. Gene
Sequencing
13.5.4.1.4. Drug
Discovery
13.5.4.1.5. Companion
Diagnostics
13.5.4.2. New
Zealand Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.4.2.1. Oncology
13.5.4.2.2. Immunology
13.5.4.2.3. CNS
13.5.4.2.4. Respiratory
13.5.4.3. New
Zealand Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
13.5.4.3.1. Pharmaceutical
Companies
13.5.4.3.2. Diagnostic
Companies
13.5.4.3.3. Healthcare
IT Companies
13.5.5. Australia
13.5.5.1. Australia
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.5.1.1. Big
Data Analytics
13.5.5.1.2. Bioinformatics
13.5.5.1.3. Gene
Sequencing
13.5.5.1.4. Drug
Discovery
13.5.5.1.5. Companion
Diagnostics
13.5.5.2. Australia
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1. Oncology
13.5.5.2.2. Immunology
13.5.5.2.3. CNS
13.5.5.2.4. Respiratory
13.5.5.3. Australia
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
13.5.5.3.1. Pharmaceutical
Companies
13.5.5.3.2. Diagnostic
Companies
13.5.5.3.3. Healthcare
IT Companies
13.5.6. South
Korea
13.5.6.1. South
Korea Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.6.1.1. Big
Data Analytics
13.5.6.1.2. Bioinformatics
13.5.6.1.3. Gene
Sequencing
13.5.6.1.4. Drug
Discovery
13.5.6.1.5. Companion
Diagnostics
13.5.6.2. South
Korea Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.2.1. Oncology
13.5.6.2.2. Immunology
13.5.6.2.3. CNS
13.5.6.2.4. Respiratory
13.5.6.3. South
Korea Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
13.5.6.3.1. Pharmaceutical
Companies
13.5.6.3.2. Diagnostic
Companies
13.5.6.3.3. Healthcare
IT Companies
13.5.7. Southeast
Asia
13.5.7.1. Southeast
Asia Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.7.1.1. Big
Data Analytics
13.5.7.1.2. Bioinformatics
13.5.7.1.3. Gene
Sequencing
13.5.7.1.4. Drug
Discovery
13.5.7.1.5. Companion
Diagnostics
13.5.7.2. Southeast
Asia Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1. Oncology
13.5.7.2.2. Immunology
13.5.7.2.3. CNS
13.5.7.2.4. Respiratory
13.5.7.3. Southeast
Asia Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
13.5.7.3.1. Pharmaceutical
Companies
13.5.7.3.2. Diagnostic
Companies
13.5.7.3.3. Healthcare
IT Companies
13.5.7.4. Southeast
Asia Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest
of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest
of Asia Pacific Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
13.5.8.1.1. Big
Data Analytics
13.5.8.1.2. Bioinformatics
13.5.8.1.3. Gene
Sequencing
13.5.8.1.4. Drug
Discovery
13.5.8.1.5. Companion
Diagnostics
13.5.8.2. Rest
of Asia Pacific Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.8.2.1. Oncology
13.5.8.2.2. Immunology
13.5.8.2.3. CNS
13.5.8.2.4. Respiratory
13.5.8.3. Rest
of Asia Pacific Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
End User
13.5.8.3.1. Pharmaceutical
Companies
13.5.8.3.2. Diagnostic
Companies
13.5.8.3.3. Healthcare
IT Companies
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Technology
13.6.3. By
Application
13.6.4. By End
User
14. Middle
East and Africa Precision Medicines Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Middle
East and Africa Precision Medicines Market Revenue (US$ Mn)
14.2. Middle
East and Africa Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
14.2.1. Big
Data Analytics
14.2.2. Bioinformatics
14.2.3. Gene Sequencing
14.2.4. Drug
Discovery
14.2.5. Companion
Diagnostics
14.3. Middle
East and Africa Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
14.3.1. Oncology
14.3.2. Immunology
14.3.3. CNS
14.3.4. Respiratory
14.4. Middle
East and Africa Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
End User
14.4.1. Pharmaceutical
Companies
14.4.2. Diagnostic
Companies
14.4.3. Healthcare
IT Companies
14.5. Middle
East and Africa Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi
Arabia Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.1.1.1. Big
Data Analytics
14.5.1.1.2. Bioinformatics
14.5.1.1.3. Gene
Sequencing
14.5.1.1.4. Drug
Discovery
14.5.1.1.5. Companion
Diagnostics
14.5.1.2. Saudi
Arabia Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.1.2.1. Oncology
14.5.1.2.2. Immunology
14.5.1.2.3. CNS
14.5.1.2.4. Respiratory
14.5.1.3. Saudi
Arabia Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
14.5.1.3.1. Pharmaceutical
Companies
14.5.1.3.2. Diagnostic
Companies
14.5.1.3.3. Healthcare
IT Companies
14.5.2. UAE
14.5.2.1. UAE
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.2.1.1. Big
Data Analytics
14.5.2.1.2. Bioinformatics
14.5.2.1.3. Gene
Sequencing
14.5.2.1.4. Drug
Discovery
14.5.2.1.5. Companion
Diagnostics
14.5.2.2. UAE
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1. Oncology
14.5.2.2.2. Immunology
14.5.2.2.3. CNS
14.5.2.2.4. Respiratory
14.5.2.3. UAE
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
14.5.2.3.1. Pharmaceutical
Companies
14.5.2.3.2. Diagnostic
Companies
14.5.2.3.3. Healthcare
IT Companies
14.5.3. Egypt
14.5.3.1. Egypt
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.3.1.1. Big
Data Analytics
14.5.3.1.2. Bioinformatics
14.5.3.1.3. Gene
Sequencing
14.5.3.1.4. Drug
Discovery
14.5.3.1.5. Companion
Diagnostics
14.5.3.2. Egypt
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1. Oncology
14.5.3.2.2. Immunology
14.5.3.2.3. CNS
14.5.3.2.4. Respiratory
14.5.3.3. Egypt
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
14.5.3.3.1. Pharmaceutical
Companies
14.5.3.3.2. Diagnostic
Companies
14.5.3.3.3. Healthcare
IT Companies
14.5.4. Kuwait
14.5.4.1. Kuwait
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.4.1.1. Big
Data Analytics
14.5.4.1.2. Bioinformatics
14.5.4.1.3. Gene
Sequencing
14.5.4.1.4. Drug
Discovery
14.5.4.1.5. Companion
Diagnostics
14.5.4.2. Kuwait
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1. Oncology
14.5.4.2.2. Immunology
14.5.4.2.3. CNS
14.5.4.2.4. Respiratory
14.5.4.3. Kuwait
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
14.5.4.3.1. Pharmaceutical
Companies
14.5.4.3.2. Diagnostic
Companies
14.5.4.3.3. Healthcare
IT Companies
14.5.5. South
Africa
14.5.5.1. South
Africa Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.5.1.1. Big
Data Analytics
14.5.5.1.2. Bioinformatics
14.5.5.1.3. Gene
Sequencing
14.5.5.1.4. Drug
Discovery
14.5.5.1.5. Companion
Diagnostics
14.5.5.2. South
Africa Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.5.2.1. Oncology
14.5.5.2.2. Immunology
14.5.5.2.3. CNS
14.5.5.2.4. Respiratory
14.5.5.3. South
Africa Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
14.5.5.3.1. Pharmaceutical
Companies
14.5.5.3.2. Diagnostic
Companies
14.5.5.3.3. Healthcare
IT Companies
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest
of Middle East & Africa Precision Medicines Market Revenue (US$ Mn) and Forecasts,
By Technology
14.5.6.1.1. Big
Data Analytics
14.5.6.1.2. Bioinformatics
14.5.6.1.3. Gene
Sequencing
14.5.6.1.4. Drug
Discovery
14.5.6.1.5. Companion
Diagnostics
14.5.6.2. Rest
of Middle East & Africa Precision Medicines Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.6.2.1. Oncology
14.5.6.2.2. Immunology
14.5.6.2.3. CNS
14.5.6.2.4. Respiratory
14.5.6.3. Rest
of Middle East & Africa Precision Medicines Market Revenue (US$ Mn) and
Forecasts, By End User
14.5.6.3.1. Pharmaceutical
Companies
14.5.6.3.2. Diagnostic
Companies
14.5.6.3.3. Healthcare
IT Companies
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Technology
14.6.3. By
Application
14.6.4. By End User
15. Latin
America Precision Medicines Market Analysis and Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Latin
America Precision Medicines Market Revenue (US$ Mn)
15.2. Latin
America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
15.2.1. Big
Data Analytics
15.2.2. Bioinformatics
15.2.3. Gene
Sequencing
15.2.4. Drug
Discovery
15.2.5. Companion
Diagnostics
15.3. Latin
America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
15.3.1. Oncology
15.3.2. Immunology
15.3.3. CNS
15.3.4. Respiratory
15.4. Latin
America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
15.4.1. Pharmaceutical
Companies
15.4.2. Diagnostic
Companies
15.4.3. Healthcare
IT Companies
15.5. Latin
America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
15.5.1.1.1. Big
Data Analytics
15.5.1.1.2. Bioinformatics
15.5.1.1.3. Gene
Sequencing
15.5.1.1.4. Drug
Discovery
15.5.1.1.5. Companion
Diagnostics
15.5.1.2. Brazil
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1. Oncology
15.5.1.2.2. Immunology
15.5.1.2.3. CNS
15.5.1.2.4. Respiratory
15.5.1.3. Brazil
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1.3.1. Pharmaceutical
Companies
15.5.1.3.2. Diagnostic
Companies
15.5.1.3.3. Healthcare
IT Companies
15.5.2. Argentina
15.5.2.1. Argentina
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Technology
15.5.2.1.1. Big
Data Analytics
15.5.2.1.2. Bioinformatics
15.5.2.1.3. Gene
Sequencing
15.5.2.1.4. Drug
Discovery
15.5.2.1.5. Companion
Diagnostics
15.5.2.2. Argentina
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1. Oncology
15.5.2.2.2. Immunology
15.5.2.2.3. CNS
15.5.2.2.4. Respiratory
15.5.2.3. Argentina
Precision Medicines Market Revenue (US$ Mn) and Forecasts, By End User
15.5.2.3.1. Pharmaceutical
Companies
15.5.2.3.2. Diagnostic
Companies
15.5.2.3.3. Healthcare
IT Companies
15.5.3. Rest of
Latin America
15.5.3.1. Rest
of Latin America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Technology
15.5.3.1.1. Big
Data Analytics
15.5.3.1.2. Bioinformatics
15.5.3.1.3. Gene
Sequencing
15.5.3.1.4. Drug
Discovery
15.5.3.1.5. Companion
Diagnostics
15.5.3.2. Rest
of Latin America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.3.2.1. Oncology
15.5.3.2.2. Immunology
15.5.3.2.3. CNS
15.5.3.2.4. Respiratory
15.5.3.3. Rest
of Latin America Precision Medicines Market Revenue (US$ Mn) and Forecasts, By
End User
15.5.3.3.1. Pharmaceutical
Companies
15.5.3.3.2. Diagnostic
Companies
15.5.3.3.3. Healthcare
IT Companies
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Technology
15.6.3. By
Application
15.6.4. By End
User
16. Competitive
Benchmarking
16.1. Market
Share Analysis, 2018
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player
Profiles
17.1. Novartis
International AG
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. QIAGEN
GmbH
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. Biocrates
Life Sciences
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT Analysis
17.3.7. Business
Strategies
17.4. Pfizer
Inc,
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Eagle
Genomics
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Tepnel
Pharma Services
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Intomics
A/S
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. NanoString
Technologies
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. Quest
Diagnostics
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. Menarini
Silicon Biosystems, Inc.
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. Teva
Pharmaceutical Industries Ltd.
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business
Strategies
17.12. Roche
Holding AG
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key
Developments
17.12.5. Financial
Analysis
17.12.6. SWOT
Analysis
17.12.7. Business Strategies
17.13. Other
Market Participants
18. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
